Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma

N Engl J Med. 2001 Dec 6;345(23):1711-2. doi: 10.1056/NEJM200112063452317.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / therapy*
  • Combined Modality Therapy
  • Humans
  • Immunotherapy
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / therapy*
  • Neoplasm Metastasis
  • Nephrectomy*
  • Recombinant Proteins
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukin-2
  • Recombinant Proteins